$262 Million is the total value of Finepoint Capital LP's 38 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 18.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TVTX | Sell | TRAVERE THERAPEUTICS INC | $19,683,720 | +91100.1% | 875,221 | -14.7% | 7.52% | +7.8% |
APLS | Sell | APELLIS PHARMACEUTICALS INC | $18,712,192 | +107956.8% | 283,690 | -15.3% | 7.15% | +27.6% |
ISEE | Buy | IVERIC BIO INC | $17,605,188 | +116105.9% | 723,600 | +2.3% | 6.72% | +37.3% |
ACAD | Sell | ACADIA PHARMACEUTICALS INC | $17,245,763 | +91951.0% | 916,353 | -22.1% | 6.59% | +8.8% |
GLPG | Buy | GALAPAGOS NVspon adr | $17,181,624 | +99078.2% | 444,659 | +13.9% | 6.56% | +17.2% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $16,919,597 | +99228.4% | 122,757 | -6.6% | 6.46% | +17.4% |
ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $16,734,040 | +102123.8% | 156,072 | +16.4% | 6.39% | +20.8% |
SAGE | Buy | SAGE THERAPEUTICS INC | $16,316,775 | +111958.1% | 388,865 | +1.9% | 6.23% | +32.4% |
FOLD | Buy | AMICUS THERAPEUTICS INC | $16,193,341 | +92741.1% | 1,460,175 | +2.2% | 6.18% | +9.7% |
PRTA | Buy | PROTHENA CORP PLC | $16,072,652 | +82514.5% | 331,600 | +2.7% | 6.14% | -2.4% |
SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $15,810,306 | +94436.6% | 614,231 | -4.5% | 6.04% | +11.7% |
CYTK | Buy | CYTOKINETICS INC | $14,561,376 | +78797.8% | 413,793 | +2.7% | 5.56% | -6.8% |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $13,946,938 | +92533.8% | 868,427 | +5.6% | 5.33% | +9.4% |
RLAY | Buy | RELAY THERAPEUTICS INC | $13,938,067 | +130406.2% | 846,270 | +18.4% | 5.32% | +54.2% |
ARVN | Buy | ARVINAS INC | $13,449,636 | +91412.8% | 492,300 | +14.6% | 5.14% | +8.1% |
CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $13,157,064 | +80544.0% | 539,445 | +4.3% | 5.03% | -4.7% |
Buy | SOLID BIOSCIENCES INC | $2,317,182 | +196939.3% | 488,857 | +123.7% | 0.88% | +132.9% | |
AACWS | ARES ACQUISITION CORP*w exp 02/02/202 | $444,141 | +188896.2% | 504,706 | 0.0% | 0.17% | +123.7% | |
HOME PLATE ACQUISITION CORP*w exp 09/30/202 | $218,730 | +3124614.3% | 690,000 | 0.0% | 0.08% | +4100.0% | ||
BTWNW | BRIDGETOWN HOLDINGS LTD*w exp 09/30/202 | $134,429 | +130413.6% | 895,000 | 0.0% | 0.05% | +54.5% | |
ROSSWS | ROSS ACQUISITION CORP II*w exp 02/01/202 | $115,192 | +523500.0% | 439,666 | 0.0% | 0.04% | +528.6% | |
CCVWS | CHURCHILL CAPITAL CORP V*w exp 10/29/202 | $114,322 | +233210.2% | 612,000 | 0.0% | 0.04% | +175.0% | |
CONYERS PARK III ACQUISITION CORP*w exp 08/12/202 | $114,333 | +134409.4% | 571,666 | 0.0% | 0.04% | +63.0% | ||
MARBLEGATE ACQUISITION CORP*w exp 08/31/202 | $110,177 | +379820.7% | 735,000 | 0.0% | 0.04% | +366.7% | ||
New | YS BIOPHARMA CO LTD*w exp 03/15/202 | $76,293 | – | 489,999 | +100.0% | 0.03% | – | |
CVIIWS | CHURCHILL CAPITAL CORP VII*w exp 02/29/202 | $67,130 | +248529.6% | 548,000 | 0.0% | 0.03% | +188.9% | |
JAWS HURRICANE ACQUISITION CORP*w exp 03/26/202 | $60,062 | +96774.2% | 387,249 | 0.0% | 0.02% | +15.0% | ||
ZIMMER ENERGY TRANSITION ACQUISITION CORP*w exp 06/16/202 | $60,118 | +88308.8% | 358,270 | 0.0% | 0.02% | +4.5% | ||
AFTERNEXT HEALTHTECH ACQUISITION CORP*w exp 99/99/999 | $61,087 | +218067.9% | 366,666 | 0.0% | 0.02% | +155.6% | ||
CCVIWS | CHURCHILL CAPITAL CORP VI*w exp 02/17/202 | $59,400 | +185525.0% | 540,000 | 0.0% | 0.02% | +130.0% | |
COMPASS DIGITAL ACQUISITION CORP*w exp 09/29/202 | $59,834 | +161613.5% | 459,906 | 0.0% | 0.02% | +91.7% | ||
SWIFTMERGE ACQUISITION CORP*w exp 12/13/202 | $59,878 | +166227.8% | 490,000 | 0.0% | 0.02% | +91.7% | ||
CORSAIR PARTNERING CORP*w exp 07/06/202 | $53,580 | +48609.1% | 334,666 | 0.0% | 0.02% | -44.4% | ||
SNRHW | SENIOR CONNECT ACQUISITION COR*w exp 12/31/202 | $51,308 | +84011.5% | 1,014,000 | 0.0% | 0.02% | 0.0% | |
CONCORD ACQUISITION CORP II*w exp 99/99/999 | $28,583 | +60714.9% | 408,333 | 0.0% | 0.01% | -26.7% | ||
FIRST LIGHT ACQUISITION GROUP INC*w exp 03/14/202 | $26,863 | +81303.0% | 655,200 | 0.0% | 0.01% | -9.1% | ||
BILANDER ACQUISITION CORP*w exp 05/19/202 | $23,887 | +72284.8% | 183,749 | 0.0% | 0.01% | -18.2% | ||
SKYDECK ACQUISITION CORP*w exp 05/13/202 | $18,088 | +258300.0% | 361,756 | 0.0% | 0.01% | +250.0% | ||
Exit | CATALYST PARTNERS ACQUISITION*w exp 05/12/202 | $0 | – | -336,666 | -100.0% | 0.00% | – | |
LVRAW | Exit | LEVERE HOLDINGS CORP*w exp 03/09/202 | $0 | – | -274,999 | -100.0% | -0.00% | – |
Exit | BERENSON ACQUISITION CORP I*w exp 08/01/202 | $0 | – | -862,499 | -100.0% | -0.01% | – | |
Exit | SUMMIT HEALTHCARE ACQUISITION CORP*w exp 06/03/202 | $0 | – | -489,999 | -100.0% | -0.04% | – | |
Exit | DISH NETWORK CORPORATIONnote 12/1 | $0 | – | -15,000,000 | -100.0% | -3.12% | – | |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -1,545,589 | -100.0% | -3.19% | – |
Exit | ALGOMA STL GROUP INC | $0 | – | -3,219,441 | -100.0% | -6.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
YPF SOCIEDAD ANONIMA | 17 | Q4 2018 | 32.7% |
IRSA INVERSIONES Y REP S A | 15 | Q2 2018 | 10.1% |
CHENIERE ENERGY INC | 14 | Q1 2018 | 29.9% |
ALLY FINL INC | 13 | Q4 2017 | 42.0% |
CRESUD S A C I F Y A | 13 | Q4 2017 | 4.0% |
BRIDGETOWN HOLDINGS LTD | 9 | Q3 2023 | 0.2% |
ARES ACQUISITION CORP | 9 | Q3 2023 | 0.2% |
CHURCHILL CAPITAL CORP V | 9 | Q3 2023 | 0.2% |
CHURCHILL CAPITAL CORP VII | 9 | Q3 2023 | 0.1% |
CHURCHILL CAPITAL CORP VI | 9 | Q3 2023 | 0.1% |
View Finepoint Capital LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View Finepoint Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.